Afsaneh Karmostaji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Afsaneh Karmostaji has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Parivash Davoodian
Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3 shared publications - Shahin Najar Peerayeh
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 shared publications Ali Hatef Salmanian
2 shared publicationsHesam Alizade
Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas
2 shared publicationsLeili Shokoohizadeh
Infectious Disease Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2 shared publications- Nahid Moradi
M.Sc. of Bacteriology, Faculty of Medicine, Infectious & Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 29  (4) , 195-198
Antibody Levels After Hepatitis B Vaccination Among 1–5-Year-Old Children in Bandar Abbas, South of Iran
Background: Hepatitis B infection is a global challenge. There are currently more than 500 million morbidities and one million mortalities due to complications annually. Considering that vaccination is the only way of prevention, this study was designed to evaluate the efficacy of the hepatitis B vaccine and measure antibody (Ab) titers in vaccinated children aged 1–5 years. Methods: Two hundred and thirty-three children aged 1–5 years referred to Bandar Abbas Children’s Hospital in 2020 were enrolled in this cross-sectional descriptive study. The required data, including the Ab titer, gender, breastfeeding, exposure to cigarette smoke, and residence (city or village), were collected using a checklist. Then, they were entered into SPSS 22 and evaluated using chi-square and Mann-Whitney statistical tests. Results: Of 233 patients, 185 (79.4%) had positive Ab titers. Accordingly, the immunogenicity of the hepatitis B vaccine was 79.4%. There was a significant correlation between age and Ab titers (P0.05). Conclusion: Overall, the rate of positive response to the hepatitis B vaccine was in the range of previous studies (69–95%). Although the hepatitis B vaccine was effective in children aged 1–5 years who were referred to Bandar Abbas Children’s Hospital, there is a possible need for continuous surveillance and a booster vaccine
- 29 December 2025
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 29  (4) , 195-198
Open AccessAntibody Levels After Hepatitis B Vaccination Among 1–5-Year-Old Children in Bandar Abbas, South of Iran
Background: Hepatitis B infection is a global challenge. There are currently more than 500 million morbidities and one million mortalities due to complications annually. Considering that vaccination is the only way of prevention, this study was designed to evaluate the efficacy of the hepatitis B vaccine and measure antibody (Ab) titers in vaccinated children aged 1–5 years. Methods: Two hundred and thirty-three children aged 1–5 years referred to Bandar Abbas Children’s Hospital in 2020 were enrolled in this cross-sectional descriptive study. The required data, including the Ab titer, gender, breastfeeding, exposure to cigarette smoke, and residence (city or village), were collected using a checklist. Then, they were entered into SPSS 22 and evaluated using chi-square and Mann-Whitney statistical tests. Results: Of 233 patients, 185 (79.4%) had positive Ab titers. Accordingly, the immunogenicity of the hepatitis B vaccine was 79.4%. There was a significant correlation between age and Ab titers (P0.05). Conclusion: Overall, the rate of positive response to the hepatitis B vaccine was in the range of previous studies (69–95%). Although the hepatitis B vaccine was effective in children aged 1–5 years who were referred to Bandar Abbas Children’s Hospital, there is a possible need for continuous surveillance and a booster vaccine
- Open Access
- 19 April 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17  (2)
New Sequence Types of Staphylococcus aureus Strains Isolated from Hospitals and Community Settings in Southern Iran
Background: Staphylococcus aureus is a significant bacterial pathogen globally recognized as the primary cause of numerous uncomplicated skin infections and severe invasive infections. The emergence of methicillin-resistant S. aureus (MRSA) poses a serious threat, leading to severe infections in both hospitals and community settings. Objectives: The aim of this study was to identify antibiotic resistance patterns and perform molecular classification of S. aureus strains isolated from both hospital and community settings in southern Iran. Methods: In this cross-sectional study conducted in Bandar Abbas between 2020 and 2021, a total of 156 clinical strains of S. aureus were collected. Antibiotic susceptibility was determined using the disk-diffusion agar method. The presence of the pvl gene, Sccmec types, and Agr group was identified through PCR analysis. Additionally, Multilocus sequence typing (MLST) was performed on selected isolates. Results: The study identified 156 strains, with 79 obtained from inpatients and 77 from outpatients, sourced from clinical samples. Among these isolates, 70 (44.8%) were classified as MRSA. The highest resistance was noted against azithromycin (83%), while the lowest resistance was observed for linezolid (5%) and gentamicin (7%). The presence of the pvl gene was detected in isolates from both hospital and community sources. Significant differences were noted in the occurrence of agr I and agr III genes between hospital and community isolates. Sccmec III was more predominant than other SCCmec types. Furthermore, MLST analysis revealed the presence of five distinct novel sequence types (STs): ST8634, ST8640, ST8650, ST8651, and ST8652. Conclusions: The findings indicate that the potential spread of hospital-acquired S. aureus strains to the community and vice versa poses a significant public health risk. This underscores the urgent need for robust infection control strategies and the identification of potential environmental and hospital sources of resistant strains, particularly MRSA strains.
- 19 April 2024
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 17  (2)
Open AccessNew Sequence Types of Staphylococcus aureus Strains Isolated from Hospitals and Community Settings in Southern Iran
Background: Staphylococcus aureus is a significant bacterial pathogen globally recognized as the primary cause of numerous uncomplicated skin infections and severe invasive infections. The emergence of methicillin-resistant S. aureus (MRSA) poses a serious threat, leading to severe infections in both hospitals and community settings. Objectives: The aim of this study was to identify antibiotic resistance patterns and perform molecular classification of S. aureus strains isolated from both hospital and community settings in southern Iran. Methods: In this cross-sectional study conducted in Bandar Abbas between 2020 and 2021, a total of 156 clinical strains of S. aureus were collected. Antibiotic susceptibility was determined using the disk-diffusion agar method. The presence of the pvl gene, Sccmec types, and Agr group was identified through PCR analysis. Additionally, Multilocus sequence typing (MLST) was performed on selected isolates. Results: The study identified 156 strains, with 79 obtained from inpatients and 77 from outpatients, sourced from clinical samples. Among these isolates, 70 (44.8%) were classified as MRSA. The highest resistance was noted against azithromycin (83%), while the lowest resistance was observed for linezolid (5%) and gentamicin (7%). The presence of the pvl gene was detected in isolates from both hospital and community sources. Significant differences were noted in the occurrence of agr I and agr III genes between hospital and community isolates. Sccmec III was more predominant than other SCCmec types. Furthermore, MLST analysis revealed the presence of five distinct novel sequence types (STs): ST8634, ST8640, ST8650, ST8651, and ST8652. Conclusions: The findings indicate that the potential spread of hospital-acquired S. aureus strains to the community and vice versa poses a significant public health risk. This underscores the urgent need for robust infection control strategies and the identification of potential environmental and hospital sources of resistant strains, particularly MRSA strains.
- Open Access
- 1 December 2023
- Published by Maad Rayan Publishing Company in Tobacco and Health
- Vol. 2  (4) , 169-174
Investigating the Association Between Smoking and Death in Patients With COVID-19 in Iran: A Meta-analysis Study
Background: With reducing the immune function of the pulmonary, smoking is considered a risk factor for contracting other infections with more severe outcomes. The present study investigates a meta-analysis of the association between smoking and the progression of COVID-19 infection in Iran. Materials and Methods: The online databases of PubMed/MEDLINE and Web of Science were searched on August 23, 2022, with the following terms: (‘‘COVID-19’’ OR ‘‘SARS-CoV-2’’ OR ‘‘Coronavirus’’), AND (‘‘smoking’’ OR ‘‘smoker*’’), AND ("Iran"). In this review, we included the studies with molecular-confirmed cases of COVID-19 and the outcome of death. The Mantel-Hensel meta-analysis method with random effects was used to investigate the relationship in the data. Results: We identified 8 papers with a total of 9199 COVID-19 patients, of whom 1861(20.2%) had the outcome of death, and 1105(12%) had a history of smoking. A total of 274 patients with a history of smoking (24.7%) were dead. The meta-analysis showed a significant association between smoking and death related to COVID-19 (odds ratio=1.22, 95% confidence interval [1.03-1.44], P=0.001). Therefore, the probability of death in COVID-19 patients with a history of smoking is about 22% higher than other people. Conclusion: Smoking is a risk factor for the progression of COVID-19, with smokers having higher odds of COVID-19 progression than non-smokers.
- 1 December 2023
- Published by Maad Rayan Publishing Company in Tobacco and Health
- Vol. 2  (4) , 169-174
Open AccessInvestigating the Association Between Smoking and Death in Patients With COVID-19 in Iran: A Meta-analysis Study
Background: With reducing the immune function of the pulmonary, smoking is considered a risk factor for contracting other infections with more severe outcomes. The present study investigates a meta-analysis of the association between smoking and the progression of COVID-19 infection in Iran. Materials and Methods: The online databases of PubMed/MEDLINE and Web of Science were searched on August 23, 2022, with the following terms: (‘‘COVID-19’’ OR ‘‘SARS-CoV-2’’ OR ‘‘Coronavirus’’), AND (‘‘smoking’’ OR ‘‘smoker*’’), AND ("Iran"). In this review, we included the studies with molecular-confirmed cases of COVID-19 and the outcome of death. The Mantel-Hensel meta-analysis method with random effects was used to investigate the relationship in the data. Results: We identified 8 papers with a total of 9199 COVID-19 patients, of whom 1861(20.2%) had the outcome of death, and 1105(12%) had a history of smoking. A total of 274 patients with a history of smoking (24.7%) were dead. The meta-analysis showed a significant association between smoking and death related to COVID-19 (odds ratio=1.22, 95% confidence interval [1.03-1.44], P=0.001). Therefore, the probability of death in COVID-19 patients with a history of smoking is about 22% higher than other people. Conclusion: Smoking is a risk factor for the progression of COVID-19, with smokers having higher odds of COVID-19 progression than non-smokers.
- 20 July 2020
- Published by Wolters Kluwer Health in Reviews and Research in Medical Microbiology
- Vol. 32  (1) , 6-11
Antimicrobial categories in describing multidrug resistance, extensive drug resistance and pan-drug resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review
Introduction and objectives: Employment of different terms in expressing resistance in Pseudomonas aeruginosa and Acinetobacter baumannii is a controversial issue. The aim of this systematic review is to assess antimicrobial categories for the terms multidrug resistance (MDR), extensive-drug resistance (XDR) and pan-drug resistance (PDR) for P. aeruginosa and A. baumannii. Materials and methods: We searched the database in the medical literature for relevant studies from 2006 up to 2016. Out of the 164 studies analyzed, 106 articles focused on definitions of MDR, XDR and PDR in A. baumannii, 53 articles focused on P. aeruginosa while five articles discussed both bacteria. Results: The most prevalent MDR, XDR and PDR A. baumannii was defined as acquired resistance to amikacin (42; 64.6%), ceftazidime (42; 64.6%) and imipenem (40; 61.5%) in MDR definition and (11; 34.4%) in XDR definition. The term MDR P. aeruginosa more often refers to resistance state to the drugs such as imipenem, ciprofloxacin (26; 76.5%) and amikacin (22; 64.7%). The most common antibiotic resistance in XDR P. aeruginosa was related to ceftazidime, piperacillin-tazobactam, ciprofloxasin (11; 73.3%) and meropenem (10; 66.7%). The term PDR P. aeruginosa was used in two studies for antibiotics such as amikacin, gentamicin and tobramycin, ceftazidime, cefepime, imipenem, meropenem and ciprofloxacin (100%). Conclusion: The current study lists the antibiotics which may be useful in clearly describing the extent of antibiotic resistance of P. aeruginosaand A. baumannii for each term.
- 20 July 2020
- Published by Wolters Kluwer Health in Reviews and Research in Medical Microbiology
- Vol. 32  (1) , 6-11
Antimicrobial categories in describing multidrug resistance, extensive drug resistance and pan-drug resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review
Introduction and objectives: Employment of different terms in expressing resistance in Pseudomonas aeruginosa and Acinetobacter baumannii is a controversial issue. The aim of this systematic review is to assess antimicrobial categories for the terms multidrug resistance (MDR), extensive-drug resistance (XDR) and pan-drug resistance (PDR) for P. aeruginosa and A. baumannii. Materials and methods: We searched the database in the medical literature for relevant studies from 2006 up to 2016. Out of the 164 studies analyzed, 106 articles focused on definitions of MDR, XDR and PDR in A. baumannii, 53 articles focused on P. aeruginosa while five articles discussed both bacteria. Results: The most prevalent MDR, XDR and PDR A. baumannii was defined as acquired resistance to amikacin (42; 64.6%), ceftazidime (42; 64.6%) and imipenem (40; 61.5%) in MDR definition and (11; 34.4%) in XDR definition. The term MDR P. aeruginosa more often refers to resistance state to the drugs such as imipenem, ciprofloxacin (26; 76.5%) and amikacin (22; 64.7%). The most common antibiotic resistance in XDR P. aeruginosa was related to ceftazidime, piperacillin-tazobactam, ciprofloxasin (11; 73.3%) and meropenem (10; 66.7%). The term PDR P. aeruginosa was used in two studies for antibiotics such as amikacin, gentamicin and tobramycin, ceftazidime, cefepime, imipenem, meropenem and ciprofloxacin (100%). Conclusion: The current study lists the antibiotics which may be useful in clearly describing the extent of antibiotic resistance of P. aeruginosaand A. baumannii for each term.
- 1 April 2020
- Published by Wolters Kluwer Health in Reviews and Research in Medical Microbiology
- Vol. 31  (2) , 92-98
Tandem repeat analysis for typing of Pseudomonas aeruginosa carrying resistance genes in southern Iran
Pseudomonas aeruginosa is known to be one of the most important causes of nosocomial infections, with high antimicrobial resistance. Thus, the current study was conducted to evaluate usefulness of multiple-locus variable number of tandem repeat (VNTR) analysis (MLVA) plan for epidemiological studies and clustering of P. aeruginosa isolated in different wards of general hospital in Bandar Abbas, south of Iran, as well as assessment of presence of integrons and resistance genes in these strains. A total of 72 clinical isolates of P. aeruginosa were isolated from the patients hospitalized in the hospital from December 2017 to June 2018 in Bandar Abbas, southern Iran. MLVA of seven VNTR markers was performed for differentiating and genetic relatedness of isolates. PCR amplification was conducted for detection of bla HSV, bla VEB , int1 and int2 genes. MLVA assay with seven loci resolved 36 different genotypes. Nearly all the isolates were classified into 6 different clonal complexes and 15 singletons. High-level resistance rate was observed in ceftazidime (44; 61%). Nine (12.5%) of these isolates showed multiple drug resistance (MDR) phenotypes. Seven (9.7%), 5 (6.9%), 46 (63.8%) and 6 (8.3%) of isolates carried bla HSV, bla VEB , int1 and int2 genes, respectively. Seven VNTR markers used in this study provided a moderate discriminatory power and differentiated 36 genotypes among 72 isolates. In addition, presence of class 1 and class 2 integrons, bla HSV and bla VEB in different clones indicated a high risk of spreading of MDR isolates among these clones. Results obtained from specification of different tandem repeats in the current study can be helpful to be used for MLVA in epidemiological surveillance of P. aeruginosa isolates in different regions.
- 1 April 2020
- Published by Wolters Kluwer Health in Reviews and Research in Medical Microbiology
- Vol. 31  (2) , 92-98
Tandem repeat analysis for typing of Pseudomonas aeruginosa carrying resistance genes in southern Iran
Pseudomonas aeruginosa is known to be one of the most important causes of nosocomial infections, with high antimicrobial resistance. Thus, the current study was conducted to evaluate usefulness of multiple-locus variable number of tandem repeat (VNTR) analysis (MLVA) plan for epidemiological studies and clustering of P. aeruginosa isolated in different wards of general hospital in Bandar Abbas, south of Iran, as well as assessment of presence of integrons and resistance genes in these strains. A total of 72 clinical isolates of P. aeruginosa were isolated from the patients hospitalized in the hospital from December 2017 to June 2018 in Bandar Abbas, southern Iran. MLVA of seven VNTR markers was performed for differentiating and genetic relatedness of isolates. PCR amplification was conducted for detection of bla HSV, bla VEB , int1 and int2 genes. MLVA assay with seven loci resolved 36 different genotypes. Nearly all the isolates were classified into 6 different clonal complexes and 15 singletons. High-level resistance rate was observed in ceftazidime (44; 61%). Nine (12.5%) of these isolates showed multiple drug resistance (MDR) phenotypes. Seven (9.7%), 5 (6.9%), 46 (63.8%) and 6 (8.3%) of isolates carried bla HSV, bla VEB , int1 and int2 genes, respectively. Seven VNTR markers used in this study provided a moderate discriminatory power and differentiated 36 genotypes among 72 isolates. In addition, presence of class 1 and class 2 integrons, bla HSV and bla VEB in different clones indicated a high risk of spreading of MDR isolates among these clones. Results obtained from specification of different tandem repeats in the current study can be helpful to be used for MLVA in epidemiological surveillance of P. aeruginosa isolates in different regions.
- Open Access
- 4 September 2019
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 23  (3) , e91764
Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study
Background: Given the significant consumption of antibiotics in hospitals and the likelihood of resistance, this study was designed to determine the pattern of meropenem and cefepime administration and prescription dose, according to Infectious Disease Society of America (IDSA) and WHO Defined Daily Dose guidelines, at Payambare-Azam Hospital in Bandar Abbas, Iran. Methods: A Retrospective study was performed from August 2016-March 2017, on 200 patients (100 patients receiving cefepime and 100 patients received meropenem) hospitalized in different wards of the hospital. A total of 189 patients were enrolled in the study, with was with consideration of the patients receiving the two antibiotics concurrently. Results: Of the examined patients, 58 (31%) were female and 131 (69%) male. In the group receiving meropenem and cefepime, 62% and 60% of the patients were above 50 years old, respectively. In terms of prescriptions, 85% cases of meropenen and 49% cefepime were performed according to the defined daily dose (DDD)’s guideline. Prescribing antibiotics for 170 (90%) of patients was empirical. Also, in the 176 (93%) patients, the dose was adjusted according to the creatinine clearance. Conclusions: Increasing the number of empirical therapy, regardless of microbial cultures and susceptibility profiles, suggests further prospective studies to evaluate the reason for this finding.
- 4 September 2019
- Published by Maad Rayan Publishing Company in hormozgan medical journal
- Vol. 23  (3) , e91764
Open AccessDrug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study
Background: Given the significant consumption of antibiotics in hospitals and the likelihood of resistance, this study was designed to determine the pattern of meropenem and cefepime administration and prescription dose, according to Infectious Disease Society of America (IDSA) and WHO Defined Daily Dose guidelines, at Payambare-Azam Hospital in Bandar Abbas, Iran. Methods: A Retrospective study was performed from August 2016-March 2017, on 200 patients (100 patients receiving cefepime and 100 patients received meropenem) hospitalized in different wards of the hospital. A total of 189 patients were enrolled in the study, with was with consideration of the patients receiving the two antibiotics concurrently. Results: Of the examined patients, 58 (31%) were female and 131 (69%) male. In the group receiving meropenem and cefepime, 62% and 60% of the patients were above 50 years old, respectively. In terms of prescriptions, 85% cases of meropenen and 49% cefepime were performed according to the defined daily dose (DDD)’s guideline. Prescribing antibiotics for 170 (90%) of patients was empirical. Also, in the 176 (93%) patients, the dose was adjusted according to the creatinine clearance. Conclusions: Increasing the number of empirical therapy, regardless of microbial cultures and susceptibility profiles, suggests further prospective studies to evaluate the reason for this finding.
- Open Access
- 4 May 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10  (5)
Genetic Determinants of Antibiotic Resistance in Hospital and Community Isolates of Klebsiella pneumoniae and Escherichia coli
Background: Multi-drug resistant Escherichia coli and Klebsiella pneumoniae with various resistance determinants are a major concern in hospital and community acquired infections around the world. Objectives: To describe the presence of blaCTX-M, blaTEM, blaPER, blaVEB, and integrons class 1, 2, 3 and extended spectrum β lactamase (ESBL) phenotype in E. coli and K. pneumoniae isolates from clinical samples of inpatients and outpatients. Methods: One hundred and eighty six E. coli and fifty-eight K. pneumoniae were collected. Antimicrobial susceptibility test was performed by disk diffusion method. Extended-spectrum beta-lactamase phenotype were screened by phenotypic confirmatory test. PCR assay was performed for blaTEM, blaCTX-M, blaPER and blaVEB and class 1, 2, 3 integrase genes. Statistical analysis was performed by chi-squared test. Results: Extended-spectrum beta-lactamase phenotype was detected in 49 (26.3%) E. coli and 19 (32.8%) K. pneumoniae isolates. BlaVEB gene in 32 (17.2%) E. coli and 5 (8.6%) K. pneumoniae isolates. BlaPER gene in 4 (2.1%) E. coli and 0 (0%) K. pneumoniae isolates. BlaCTX-M gene in 113 (60.7%) E. coli and 34 (58.6%) K. pneumoniae isolates. BlaTEM gene in 106 (57%) E. coli and 25 (43.1%) K. pneumoniae isolates. One hundred and nine (58.6%) of E. coli and 33 (56.9%) of K. pneumoniae were carrying Class 1 integron and 18 (9.7%) of E. coli and 3 (5.2%) of K. pneumoniae were carrying Class 2 integron. Class 3 integron was not detected. Conclusions: High prevalence of ESBLs in E. coli and K. pneumoniae isolated from the community and hospital acquired infections could lead to the wide spread of multi-drug resistance clones that also contain new mechanism of resistance. Keywords: Community-Acquired Infection; β Lactamases; Hospital Infections; Klebsiella pneumoniae; Escherichia coli; Integrons
- 4 May 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10  (5)
Open AccessGenetic Determinants of Antibiotic Resistance in Hospital and Community Isolates of Klebsiella pneumoniae and Escherichia coli
Background: Multi-drug resistant Escherichia coli and Klebsiella pneumoniae with various resistance determinants are a major concern in hospital and community acquired infections around the world. Objectives: To describe the presence of blaCTX-M, blaTEM, blaPER, blaVEB, and integrons class 1, 2, 3 and extended spectrum β lactamase (ESBL) phenotype in E. coli and K. pneumoniae isolates from clinical samples of inpatients and outpatients. Methods: One hundred and eighty six E. coli and fifty-eight K. pneumoniae were collected. Antimicrobial susceptibility test was performed by disk diffusion method. Extended-spectrum beta-lactamase phenotype were screened by phenotypic confirmatory test. PCR assay was performed for blaTEM, blaCTX-M, blaPER and blaVEB and class 1, 2, 3 integrase genes. Statistical analysis was performed by chi-squared test. Results: Extended-spectrum beta-lactamase phenotype was detected in 49 (26.3%) E. coli and 19 (32.8%) K. pneumoniae isolates. BlaVEB gene in 32 (17.2%) E. coli and 5 (8.6%) K. pneumoniae isolates. BlaPER gene in 4 (2.1%) E. coli and 0 (0%) K. pneumoniae isolates. BlaCTX-M gene in 113 (60.7%) E. coli and 34 (58.6%) K. pneumoniae isolates. BlaTEM gene in 106 (57%) E. coli and 25 (43.1%) K. pneumoniae isolates. One hundred and nine (58.6%) of E. coli and 33 (56.9%) of K. pneumoniae were carrying Class 1 integron and 18 (9.7%) of E. coli and 3 (5.2%) of K. pneumoniae were carrying Class 2 integron. Class 3 integron was not detected. Conclusions: High prevalence of ESBLs in E. coli and K. pneumoniae isolated from the community and hospital acquired infections could lead to the wide spread of multi-drug resistance clones that also contain new mechanism of resistance. Keywords: Community-Acquired Infection; β Lactamases; Hospital Infections; Klebsiella pneumoniae; Escherichia coli; Integrons
- Open Access
- 1 January 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in Infection, Epidemiology and Medicine
- Vol. 3  (1) , 1-5
Antibiotic Resistance Pattern and Evaluation of blaOXA-10, blaPER-1, blaVEB, blaSHV Genes in Clinical Isolates of Pseudomonas aeruginosa Isolated from Hospital in South of Iran in 2014-2015
Background: Pseudomonas aeruginosa is one of the main causes of nosocomial infections with a mortality rate up to 40-50%. Resistance to antibiotics is a global challenge in the treatment of infections caused by this bacterium. The Class A beta-lactamases genes, including blaSHV, blaPER, blaVEB, are the most common causes of resistance in this microorganism. This study was conducted to determine antibiotic resistance pattern and the presence of blaper, blaveb, blashv and blaoxa-10 genes in clinical isolates of P. aeruginosa isolated from patients in a hospital in Bandar Abbas. Materials and Methods: This cross-sectional study was conducted on 72 P. aeruginosa clinical isolates. Antibiotic susceptibility testing was performed by disk diffusion method according to the clinical Laboratory Standard Institute. MIC (Minimum inhibitory concentration) of ceftazidime was performed by E-Test. Polymerase chain reaction (PCR) was performed to identify blashv, blaveb-1, blaoxa-10, and blaper-1 genes. Results: Most of the isolates were detected from intensive care unit and urine samples. The highest resistance rate which was observed to sulfamethoxazole and ceftazidime, were 68 (94.44%) and 44 (61.11%), respectively. 27.8% of these isolates were multidrug resistance. Among 44 ceftazidime resistance isolates, 15 isolates (34%) showed MIC ≥32 µg.ml in the E- test. The prevalence rates of genes were 4.16, 12.5, 8.33, and 1.38% for blaOxa-10, blaShv, blaVeb-1, and blaPer-1 genes, respectively. Conclusion: The ceftazidime resistance rate and the prevalence rate of resistance genes in the present study were lower than other Iranian studies. However, isolation of these genes is alarming that excessive use of antibiotics can lead to over expression of resistance genes and bacterial efflux pumps and the emergence of MDR phenotypes.
- 1 January 2017
- Published by CASRP: Center of Advanced Scientific Research and Publications in Infection, Epidemiology and Medicine
- Vol. 3  (1) , 1-5
Open AccessAntibiotic Resistance Pattern and Evaluation of blaOXA-10, blaPER-1, blaVEB, blaSHV Genes in Clinical Isolates of Pseudomonas aeruginosa Isolated from Hospital in South of Iran in 2014-2015
Background: Pseudomonas aeruginosa is one of the main causes of nosocomial infections with a mortality rate up to 40-50%. Resistance to antibiotics is a global challenge in the treatment of infections caused by this bacterium. The Class A beta-lactamases genes, including blaSHV, blaPER, blaVEB, are the most common causes of resistance in this microorganism. This study was conducted to determine antibiotic resistance pattern and the presence of blaper, blaveb, blashv and blaoxa-10 genes in clinical isolates of P. aeruginosa isolated from patients in a hospital in Bandar Abbas. Materials and Methods: This cross-sectional study was conducted on 72 P. aeruginosa clinical isolates. Antibiotic susceptibility testing was performed by disk diffusion method according to the clinical Laboratory Standard Institute. MIC (Minimum inhibitory concentration) of ceftazidime was performed by E-Test. Polymerase chain reaction (PCR) was performed to identify blashv, blaveb-1, blaoxa-10, and blaper-1 genes. Results: Most of the isolates were detected from intensive care unit and urine samples. The highest resistance rate which was observed to sulfamethoxazole and ceftazidime, were 68 (94.44%) and 44 (61.11%), respectively. 27.8% of these isolates were multidrug resistance. Among 44 ceftazidime resistance isolates, 15 isolates (34%) showed MIC ≥32 µg.ml in the E- test. The prevalence rates of genes were 4.16, 12.5, 8.33, and 1.38% for blaOxa-10, blaShv, blaVeb-1, and blaPer-1 genes, respectively. Conclusion: The ceftazidime resistance rate and the prevalence rate of resistance genes in the present study were lower than other Iranian studies. However, isolation of these genes is alarming that excessive use of antibiotics can lead to over expression of resistance genes and bacterial efflux pumps and the emergence of MDR phenotypes.
- Open Access
- 25 November 2015
- Published by Knowledge Kingdom Publishing in Electronic Physiciane
- Vol. 7  (7) , 1529-1534
Seasonal Distribution of Fungi in Soil Found in Two Hospitals in Bandar Abbas, Iran
Seasonal Distribution of Fungi in Soil Found in Two Hospitals in Bandar Abbas, Iran
- 25 November 2015
- Published by Knowledge Kingdom Publishing in Electronic Physiciane
- Vol. 7  (7) , 1529-1534
Open AccessSeasonal Distribution of Fungi in Soil Found in Two Hospitals in Bandar Abbas, Iran
Seasonal Distribution of Fungi in Soil Found in Two Hospitals in Bandar Abbas, Iran
- Open Access
- 25 July 2015
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 8  (7) , e27021
Molecular Identification of Resistance Determinants, Integrons and Genetic Relatedness of Extensively Drug Resistant Acinetobacter baumannii Isolated From Hospitals in Tehran, Iran
Background: Acinetobacter baumannii has emerged as an important nosocomial pathogen. Hospital outbreaks of extensively drug resistant (XDR) A. baumannii are a great concern. Objectives: Aims of this study were to characterize the resistance determinants and genetic relatedness of (XDR) A. baumannii isolates in hospitals in Tehran, Iran. Materials and Methods: During a three-year study, clinical isolates of A. baumannii were collected from two hospitals in Tehran, Iran. Susceptibility testing to antibiotics was performed by disk diffusion method and XDR A. baumannii isolates were identified. Genes’ encoding for carbapenemase production and integrons were identified by PCR. MICs of imipenem and meropenem were determined by agar dilution. Multiple locus variable-number tandem repeat analysis (MLVA) typing was used to determine genetic relationships of XDR isolates. Results: Using PCR for amplification of blaOXA-51, 93.9% (123.131) of isolates were identified as A. baumannii and 24.4% (30.123) were XDR. These isolates were resistant to gentamicin, ciprofloxacin, amikacin, cotrimoxazole, cefepime, cefotaxime, aztreonam and ceftazidime. Thirty percent of the isolates were resistant to tigecycline. All isolates were susceptible to colistin and polymyxin-B, while 93.3% (28.30) possessed blaOXA-23-like and 6.7% (2.30) possessed blaOXA-24-like. All isolates possessed insertion sequence (ISAba1) in the upstream region of the OXA-23-like gene. Almost 96.7% (29.30) of the isolates were positive for class I integron and 43.3% (13.30) for class II. These isolates were also positive for class I. Class III integron was not detected. MLVA typing of XDR isolates showed seven clonally complexes and 16 singletons. Conclusions: The population structure of the A. baumannii isolates in our hospitals was genetically diverse. A significant association between XDR pattern and presence of class 1 integron (P < 0.001) was found indicating that many antibiotic resistance determinants are involved in development of XDR strains. Keywords: Extensively Drug-Resistant; Integrons; Oxacillinase; Acinetobacter baumannii
- 25 July 2015
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 8  (7) , e27021
Open AccessMolecular Identification of Resistance Determinants, Integrons and Genetic Relatedness of Extensively Drug Resistant Acinetobacter baumannii Isolated From Hospitals in Tehran, Iran
Background: Acinetobacter baumannii has emerged as an important nosocomial pathogen. Hospital outbreaks of extensively drug resistant (XDR) A. baumannii are a great concern. Objectives: Aims of this study were to characterize the resistance determinants and genetic relatedness of (XDR) A. baumannii isolates in hospitals in Tehran, Iran. Materials and Methods: During a three-year study, clinical isolates of A. baumannii were collected from two hospitals in Tehran, Iran. Susceptibility testing to antibiotics was performed by disk diffusion method and XDR A. baumannii isolates were identified. Genes’ encoding for carbapenemase production and integrons were identified by PCR. MICs of imipenem and meropenem were determined by agar dilution. Multiple locus variable-number tandem repeat analysis (MLVA) typing was used to determine genetic relationships of XDR isolates. Results: Using PCR for amplification of blaOXA-51, 93.9% (123.131) of isolates were identified as A. baumannii and 24.4% (30.123) were XDR. These isolates were resistant to gentamicin, ciprofloxacin, amikacin, cotrimoxazole, cefepime, cefotaxime, aztreonam and ceftazidime. Thirty percent of the isolates were resistant to tigecycline. All isolates were susceptible to colistin and polymyxin-B, while 93.3% (28.30) possessed blaOXA-23-like and 6.7% (2.30) possessed blaOXA-24-like. All isolates possessed insertion sequence (ISAba1) in the upstream region of the OXA-23-like gene. Almost 96.7% (29.30) of the isolates were positive for class I integron and 43.3% (13.30) for class II. These isolates were also positive for class I. Class III integron was not detected. MLVA typing of XDR isolates showed seven clonally complexes and 16 singletons. Conclusions: The population structure of the A. baumannii isolates in our hospitals was genetically diverse. A significant association between XDR pattern and presence of class 1 integron (P < 0.001) was found indicating that many antibiotic resistance determinants are involved in development of XDR strains. Keywords: Extensively Drug-Resistant; Integrons; Oxacillinase; Acinetobacter baumannii